Methylation-associated mutagenesis underlies variation in the mutation spectrum across eukaryotes

Mutation spectra vary across genetic and environmental contexts, leading to differences between and within species. Most research on mutation spectrum has focused on trinucleotide (3-mer) mutation types in mammals, limiting the breadth and depth of variation surveyed. In this study, we use whole-genome resequencing data across 108 eukaryotic species-including mammals, fish, plants, and invertebrates-to characterize pentanucleotide (5-mer) noncoding mutation spectra using a Bayesian approach. Our findings reveal cytosine transition mutability at CpG sites and other sources of variation in the transition/transversion ratio as the main drivers of variation in mutation spectra across eukaryotes. We find that inferred CpG mutation rates almost perfectly predict genomic CpG depletion but are not predicted by genome-wide average CpG methylation levels. Together, our results illustrate the pivotal role of mutagenesis in shaping genome composition across eukaryotes and highlight a gap in knowledge about the mechanisms governing mutation rates.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-03-13
DOI
https://doi.org/10.1073/pnas.2516368123
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Methylation-associated mutagenesis underlies variation in the mutation spectrum across eukaryotes

Benjamin Franklin Voight, Ziyue Gao, Fabián Ramos-Almodóvar, Iain Mathieson
Proceedings of the National Academy of Sciences
Cancer Genomics and Diagnostics
article

Methylation-associated mutagenesis underlies variation in the mutation spectrum across eukaryotes

Benjamin Franklin Voight, Ziyue Gao, Fabián Ramos-Almodóvar, Iain Mathieson
article en

Abstract

Mutation spectra vary across genetic and environmental contexts, leading to differences between and within species. Most research on mutation spectrum has focused on trinucleotide (3-mer) mutation types in mammals, limiting the breadth and depth of variation surveyed. In this study, we use whole-genome resequencing data across 108 eukaryotic species-including mammals, fish, plants, and invertebrates-to characterize pentanucleotide (5-mer) noncoding mutation spectra using a Bayesian approach. Our findings reveal cytosine transition mutability at CpG sites and other sources of variation in the transition/transversion ratio as the main drivers of variation in mutation spectra across eukaryotes. We find that inferred CpG mutation rates almost perfectly predict genomic CpG depletion but are not predicted by genome-wide average CpG methylation levels. Together, our results illustrate the pivotal role of mutagenesis in shaping genome composition across eukaryotes and highlight a gap in knowledge about the mechanisms governing mutation rates.

Proceedings of the National Academy of SciencesVol. 123(11)
Translational Therapeutics (United States) (US), University of Pennsylvania (US)
Alfred P. Sloan Foundation, University of Pennsylvania, National Institutes of Health, National Institute of General Medical Sciences, National Institute of Environmental Health Sciences
Openalex Percentile: Top 22%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.